Is Polymyalgia Rheumatica hereditary?

Polymyalgia Rheumatica is not considered a hereditary or strictly genetic disease, as it does not follow a simple Mendelian inheritance pattern. While there is no single "gene" for Polymyalgia Rheumatica, research suggests a multifactorial predisposition where a combination of genetic susceptibility—particularly involving human leukocyte antigen (HLA) variants—and environmental triggers may increase individual risk.

Is Polymyalgia Rheumatica hereditary?

Polymyalgia Rheumatica is not passed down through families in the way that conditions like cystic fibrosis or Huntington’s disease are. It is not an autosomal or X-linked disorder. Instead, it is classified as a multifactorial inflammatory condition. While some studies have identified an association between Polymyalgia Rheumatica and certain HLA-DRB1 alleles, having these genetic markers does not guarantee that an individual will develop the disease, nor does the absence of them provide immunity.

How do genetics influence risk?

Because Polymyalgia Rheumatica is multifactorial, it is impossible to provide a specific inheritance percentage for children of an affected parent. The risk of a child developing the condition is not significantly higher than that of the general population. Factors contributing to the development of Polymyalgia Rheumatica include:

• Age: It almost exclusively affects individuals over the age of 50.


• Genetic predisposition: Certain HLA-DRB1 alleles are more common in patients, suggesting an immune system component.


• Environmental triggers: Potential exposure to viral or bacterial infections may act as a catalyst in genetically susceptible individuals.


• Immune system dysregulation: The condition is driven by systemic inflammation rather than a primary genetic mutation.

Is genetic testing available for Polymyalgia Rheumatica?

There is currently no clinical genetic test available or recommended for the diagnosis of Polymyalgia Rheumatica. Diagnosis is based entirely on clinical symptoms, physical examination, and blood markers of inflammation (such as ESR and CRP). Genetic counseling is generally not indicated for families, as there is no clear inheritance pattern to track or predict through prenatal or carrier testing. De novo mutations are not a factor in the development of this disease.

Next steps

• Consult a rheumatologist to confirm your diagnosis through standardized clinical criteria.


• Monitor for symptoms like stiffness and pain in the shoulders and hips.


• Join the community of 52 people with Polymyalgia Rheumatica at DiseaseMaps.org to share experiences.


• Focus on managing inflammation through prescribed corticosteroid therapy under professional supervision.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Polymyalgia Rheumatica


• Orphanet: Rare Disease Database - Polymyalgia Rheumatica


• PubMed: "Genetic susceptibility and the role of HLA-DRB1 in Polymyalgia Rheumatica"


• Arthritis Foundation: Clinical guidelines for inflammatory rheumatic diseases